We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$106B
AUM Growth
+$6.52B
Cap. Flow
+$4.41B
Cap. Flow %
4.14%
Top 10 Hldgs %
13.68%
Holding
3,236
New
179
Increased
2,227
Reduced
440
Closed
133

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$115M
2
AAPL icon
Apple
AAPL
+$95.4M
3
DXC icon
DXC Technology
DXC
+$91M
4
PFE icon
Pfizer
PFE
+$66.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$60.4M

Sector Composition

Rank Sector Weight
1 Technology 14.68%
2 Financials 14.59%
3 Healthcare 13.17%
4 Industrials 11.08%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBGI icon
3051
Beasley Broadcasting Group
BBGI
$35.3M
$173K ﹤0.01%
+880
New +$189K
WG
3052
DELISTED
Willbros Group
WG
$172K ﹤0.01%
69,500
OPTT icon
3053
Ocean Power Technologies
OPTT
$41.5M
$168K ﹤0.01%
6,087
XONE
3054
DELISTED
The ExOne Company
XONE
$168K ﹤0.01%
14,600
FFNW
3055
DELISTED
First Financial Northwest, Inc
FFNW
$167K ﹤0.01%
10,300
FBRX icon
3056
Forte Biosciences
FBRX
$1.57B
$165K ﹤0.01%
+37
New +$208K
RLH
3057
DELISTED
Red Lions Hotel Corporation
RLH
$164K ﹤0.01%
22,200
TRHC
3058
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$163K ﹤0.01%
10,800
AST
3059
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$163K ﹤0.01%
45,825
CIE
3060
DELISTED
Cobalt International Energy, Inc
CIE
$161K ﹤0.01%
65,151
+3,051
+5% +$14.4K
IMDZ
3061
DELISTED
Immune Design Corp.
IMDZ
$159K ﹤0.01%
16,243
ATCO
3062
DELISTED
Atlas Corp.
ATCO
$157K ﹤0.01%
+21,986
New +$137K
OMED
3063
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$154K ﹤0.01%
46,012
-35,987
-44% -$149K
OVID icon
3064
Ovid Therapeutics
OVID
$427M
$153K ﹤0.01%
+14,500
New +$189K
MTNB icon
3065
Matinas BioPharma
MTNB
$1.91M
$152K ﹤0.01%
+1,790
New +$240K
TAX
3066
DELISTED
Liberty Tax, Inc. Class A
TAX
$152K ﹤0.01%
11,700
MNKD icon
3067
MannKind Corp
MNKD
$1.19B
$151K ﹤0.01%
106,397
-28,680
-21% -$36.9K
PTGX icon
3068
Protagonist Therapeutics
PTGX
$8.55B
$150K ﹤0.01%
13,200
GWRS icon
3069
Global Water Resources
GWRS
$215M
$149K ﹤0.01%
15,000
SNDX icon
3070
Syndax Pharmaceuticals
SNDX
$1.7B
$142K ﹤0.01%
10,100
UCP
3071
DELISTED
UCP, Inc.
UCP
$142K ﹤0.01%
12,900
NOG icon
3072
Northern Oil and Gas
NOG
$2.29B
$141K ﹤0.01%
10,061
-1,788
-15% -$34.6K
TUES
3073
DELISTED
Tuesday Morning Corp
TUES
$124K ﹤0.01%
65,091
-310,132
-83% -$758K
SENS icon
3074
Senseonics Holdings Inc
SENS
$254M
$120K ﹤0.01%
3,308
-849
-20% -$26.9K
SMRT
3075
DELISTED
Stein Mart Inc
SMRT
$106K ﹤0.01%
62,495
-5,758
-8% -$11.4K

Similar funds

Charles Schwab's Q2 2017 Portfolio in Review

As of Q2 2017, Charles Schwab held 3,236 positions worth $106B, up 6.5% from $99.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $4.41B of net new capital in Q2 2017, opening 179 new positions and adding to 2,227 existing holdings. Its largest new stake was DXC Technology: 1,371,360 shares worth $91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was HP, an estimated $50.3M trimmed.

  • Charles Schwab's largest Q2 2017 buy was DXC Technology: 1,371,360 shares worth $91M.
  • Charles Schwab added most to ExxonMobil in Q2 2017, an estimated $115M increase.
  • Charles Schwab's biggest Q2 2017 reduction was HP, cutting an estimated $50.3M.
  • Charles Schwab fully exited Yahoo Inc in Q2 2017, selling an estimated $121M.
  • Charles Schwab's ten largest holdings make up 14% of its $106B portfolio in Q2 2017.
  • Charles Schwab opened 179 new positions and closed 133 in Q2 2017.
  • Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $106B.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.